|Articles|February 1, 2005
Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca
Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Experts recommend postpartum psychosis be classified as its own disorder
2
Supporting employees with PCOS: The overlooked opportunity in inclusive fertility benefits
3
Contemporary OB/GYN week in review: PCOS subtypes, fertility prediction, and more
4
Unmet Needs in Managing Vasomotor Symptoms in Menopause
5












